What is Bioworks?
Established in 1984, Bioworks has carved out a specialized niche in the design and distribution of custom foot orthotics and orthopedic bracing solutions. The company serves a diverse patient demographic, including pediatric populations, by providing essential rehabilitation and pain management products. Their portfolio ranges from custom arch supports and knee CPM machines to advanced cranial remolding helmets. By maintaining strong collaborative relationships with healthcare providers and ensuring in-network status with major insurance carriers, Bioworks has solidified its reputation as a reliable provider of high-quality orthopedic care. Their dual-facility footprint in Cincinnati serves as a testament to their enduring commitment to patient-centric service and clinical excellence.
How much funding has Bioworks raised?
Bioworks has raised a total of $170K across 1 funding round:
Debt
$170K
Debt (2021): $170K with participation from PPP
Key Investors in Bioworks
PPP
Public-Private Partnership
What's next for Bioworks?
With the recent infusion of capital, Bioworks is poised to enter a new phase of operational scaling and technological integration. The strategic focus will likely shift toward enhancing production efficiencies for their custom bracing solutions and potentially expanding their clinical reach. As the company navigates the complexities of the late-stage growth environment, the management team will prioritize the optimization of their supply chain and the deepening of their provider network. This financial backing provides the necessary runway to invest in advanced manufacturing capabilities, ensuring that Bioworks remains at the forefront of orthopedic innovation while continuing to deliver superior patient outcomes in a rapidly evolving healthcare market.
See full Bioworks company page
